UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by IAM Advisory LLC

IAM Advisory LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,687 shares of the healthcare conglomerate’s stock after acquiring an additional 63 shares during the quarter. IAM Advisory LLC’s holdings in UnitedHealth Group were worth $1,878,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of UNH. Delos Wealth Advisors LLC increased its position in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares in the last quarter. True Wealth Design LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $31,000. Red Tortoise LLC increased its position in shares of UnitedHealth Group by 45.1% in the first quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after buying an additional 23 shares in the last quarter. Ruedi Wealth Management Inc. increased its position in shares of UnitedHealth Group by 58.3% in the first quarter. Ruedi Wealth Management Inc. now owns 76 shares of the healthcare conglomerate’s stock valued at $38,000 after buying an additional 28 shares in the last quarter. Finally, Transcendent Capital Group LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $40,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the subject of several research reports. Morgan Stanley boosted their price target on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Wells Fargo & Company boosted their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. UBS Group boosted their price objective on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research note on Thursday, July 18th. Finally, Royal Bank of Canada boosted their price objective on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Performance

NYSE:UNH traded down $7.48 during mid-day trading on Friday, reaching $558.76. 2,976,835 shares of the stock were exchanged, compared to its average volume of 4,283,194. The company has a 50 day simple moving average of $521.83 and a 200-day simple moving average of $504.89. The stock has a market capitalization of $514.27 billion, a P/E ratio of 34.15, a P/E/G ratio of 1.58 and a beta of 0.59. The company has a quick ratio of 0.85, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $591.54.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter last year, the business posted $6.14 EPS. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.50%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.